It’s being called an epidemic. The alarming uptick in the diagnosis of basal and squamous cell (non-melanoma) skin cancer means more and more people will require skin cancer treatment in the coming years. As the fastest growing cancer in the world, about four million people are diagnosed with non-melanoma skin cancer (NMSC)—2.5 times more than all the other cancers combined. By 2020, experts predict that number will grow 50 percent to nearly six million—fueled by the Baby Boomer generation.
With the majority of NMSC occurring in people over the age of 60, medical conditions such as diabetes and cardiac disease that can make surgical skin cancer treatment a serious health risk. For others diagnosed with NMSC on their head and neck, the potential for unsightly scarring and reconstructive plastic surgery means surgical treatment is less than ideal.